AAAAAA

   
Results: 1-8 |
Results: 8
PULMONARY BIOAVAILABILITY OF A PHOSPHOROTHIOATE OLIGONUCLEOTIDE (CGP 64128A) - COMPARISON WITH OTHER DELIVERY ROUTES
Authors: NICKLIN PL BAYLEY D GIDDINGS J CRAIG SJ CUMMINS LL HASTEWELL JG PHILLIPS JA
Citation: Pl. Nicklin et al., PULMONARY BIOAVAILABILITY OF A PHOSPHOROTHIOATE OLIGONUCLEOTIDE (CGP 64128A) - COMPARISON WITH OTHER DELIVERY ROUTES, Pharmaceutical research, 15(4), 1998, pp. 583-591
COADMINISTRATION OF POLYANIONS WITH A PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE (CGP 69846A) - A ROLE FOR THE SCAVENGER RECEPTOR IN ITS IN-VIVODISPOSITION
Authors: STEWARD A CHRISTIAN RA HAMILTON KO NICKLIN PL
Citation: A. Steward et al., COADMINISTRATION OF POLYANIONS WITH A PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE (CGP 69846A) - A ROLE FOR THE SCAVENGER RECEPTOR IN ITS IN-VIVODISPOSITION, Biochemical pharmacology, 56(4), 1998, pp. 509-516
PRECLINICAL PROFILING OF MODIFIED OLIGONUCLEOTIDES - ANTICOAGULATION AND PHARMACOKINETIC PROPERTIES
Authors: NICKLIN PL AMBLER J MITCHELSON A BAYLEY D PHILLIPS JA CRAIG SJ MONIA BP
Citation: Pl. Nicklin et al., PRECLINICAL PROFILING OF MODIFIED OLIGONUCLEOTIDES - ANTICOAGULATION AND PHARMACOKINETIC PROPERTIES, Nucleosides & nucleotides, 16(7-9), 1997, pp. 1145-1153
PHARMACOKINETICS, METABOLISM, AND ELIMINATION OF A 20-MER PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE (CGP 69846A) AFTER INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION
Authors: PHILLIPS JA CRAIG SJ BAYLEY D CHRISTIAN RA GEARY R NICKLIN PL
Citation: Ja. Phillips et al., PHARMACOKINETICS, METABOLISM, AND ELIMINATION OF A 20-MER PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE (CGP 69846A) AFTER INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION, Biochemical pharmacology, 54(6), 1997, pp. 657-668
INTERACTIONS OF PHOSPHODIESTER AND PHOSPHOROTHIOATE OLIGONUCLEOTIDES WITH INTESTINAL EPITHELIAL CACO-2 CELLS
Authors: BECK GF IRWIN WJ NICKLIN PL AKHTAR S
Citation: Gf. Beck et al., INTERACTIONS OF PHOSPHODIESTER AND PHOSPHOROTHIOATE OLIGONUCLEOTIDES WITH INTESTINAL EPITHELIAL CACO-2 CELLS, Pharmaceutical research, 13(7), 1996, pp. 1028-1037
UPTAKE AND TRANSPORT OF THE ACE-INHIBITOR CERONAPRIL (SQ-29852) BY MONOLAYERS OF HUMAN INTESTINAL ABSORPTIVE (CACO-2) CELLS IN-VITRO
Authors: NICKLIN PL IRWIN WJ TIMMINS P MORRISON RA
Citation: Pl. Nicklin et al., UPTAKE AND TRANSPORT OF THE ACE-INHIBITOR CERONAPRIL (SQ-29852) BY MONOLAYERS OF HUMAN INTESTINAL ABSORPTIVE (CACO-2) CELLS IN-VITRO, International journal of pharmaceutics, 140(2), 1996, pp. 175-183
DEVELOPMENT OF A MINIMUM-CALCIUM CACO-2 MONOLAYER MODEL - CALCIUM ANDMAGNESIUM-IONS RETARD THE TRANSPORT OF PAMIDRONATE
Authors: NICKLIN PL IRWIN WJ HASSAN IF MACKAY M
Citation: Pl. Nicklin et al., DEVELOPMENT OF A MINIMUM-CALCIUM CACO-2 MONOLAYER MODEL - CALCIUM ANDMAGNESIUM-IONS RETARD THE TRANSPORT OF PAMIDRONATE, International journal of pharmaceutics, 123(2), 1995, pp. 187-197
THE TRANSPORT OF ACIDIC AMINO-ACIDS AND THEIR ANALOGS ACROSS MONOLAYERS OF HUMAN INTESTINAL ABSORPTIVE (CACO-2) CELLS IN-VITRO
Authors: NICKLIN PL IRWIN WJ HASSAN IF MACKAY M DIXON HBF
Citation: Pl. Nicklin et al., THE TRANSPORT OF ACIDIC AMINO-ACIDS AND THEIR ANALOGS ACROSS MONOLAYERS OF HUMAN INTESTINAL ABSORPTIVE (CACO-2) CELLS IN-VITRO, Biochimica et biophysica acta. Molecular cell research, 1269(2), 1995, pp. 176-186
Risultati: 1-8 |